Nicole Salazar-Austin completed her undergraduate and medical training at the Massachusetts Institute of Technology, Harvard Medical School and the Children’s Hospital of Philadelphia. She spent several years as a global health corps physician with the Baylor International Pediatric AIDS Initiative in eSwatini before returning to the US and completing a fellowship in pediatric infectious diseases at the Johns Hopkins School of Medicine and a Master’s degree in epidemiology at the Johns Hopkins Bloomberg School of Public Health. She’s now an Assistant Professor in the Department of Pediatrics at the Johns Hopkins School of Medicine. Her research focuses on combining existing and new biomedical interventions in tuberculosis with novel health care delivery models to improve implementation of TB preventive treatment in TB-exposed pregnant women, children and adolescents with and without HIV worldwide. She’s also leading two PK studies that will define 1HP dosing and safety in children less than 15 years of age (IMPAACT 2024) and a second that will define the drug-drug interaction between 3HP and dolutegravir in children < 18 years of age (DOLPHIN Kids).